2018-2023 Global Trazodone Hydrochloride (API) Consumption Market Report
NxtGen Reports recently added a new market research report in its offerings titled, "2018-2023 Global Trazodone Hydrochloride (API) Consumption Market Report".
(EMAILWIRE.COM, October 19, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of global Trazodone Hydrochloride (API) market for 2018-2023.
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Only few manufacturers can produce trazodone hydrochloride (API) in USA. Teva, the Israeli company, has a production base in the United States, dominates the market with the production market share of 92.98% in 2015
The price of trazodone hydrochloride (API) has a overall upward trend from 2011 to 2016, with a little decrease in 2012 and 2015. The average price of trazodone hydrochloride (API) is about 218 USD/Kg in 2015. The average product profit margin is about 55.82% in 2015, and it also experienced fluctuations in recent years.
Over the next five years, this report projects that Trazodone Hydrochloride (API) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Trazodone Hydrochloride (API) market by product type, application, key manufacturers and key regions.
To calculate the market size, this report considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Trazodone Hydrochloride (API)
Others
Segmentation by application:
Antidepression
Anxiolytic
Hypnotic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Teva
Angelini
Mylan
Fermion
The Piramal Group
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Trazodone Hydrochloride (API) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Trazodone Hydrochloride (API) market by identifying its various subsegments.
Focuses on the key global Trazodone Hydrochloride (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Trazodone Hydrochloride (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Trazodone Hydrochloride (API) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
To get Free Sample or to Buy this report at discounted price visit: https://www.nxtgenreports.com/market-research-reports/2018-2023-global-trazodone-hydrochloride-api
If you have any special requirements, kindly Contact Us and we will offer you the report as you want.
About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.
Contact Information:
Madhuri Vetal
NxtGen Reports
Email: sales@nxtgenreports.com
Phone: +918551022388
More Report at: https://www.nxtgenreports.com/market-research-reports
Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Only few manufacturers can produce trazodone hydrochloride (API) in USA. Teva, the Israeli company, has a production base in the United States, dominates the market with the production market share of 92.98% in 2015
The price of trazodone hydrochloride (API) has a overall upward trend from 2011 to 2016, with a little decrease in 2012 and 2015. The average price of trazodone hydrochloride (API) is about 218 USD/Kg in 2015. The average product profit margin is about 55.82% in 2015, and it also experienced fluctuations in recent years.
Over the next five years, this report projects that Trazodone Hydrochloride (API) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Trazodone Hydrochloride (API) market by product type, application, key manufacturers and key regions.
To calculate the market size, this report considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Trazodone Hydrochloride (API)
Others
Segmentation by application:
Antidepression
Anxiolytic
Hypnotic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Teva
Angelini
Mylan
Fermion
The Piramal Group
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Trazodone Hydrochloride (API) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Trazodone Hydrochloride (API) market by identifying its various subsegments.
Focuses on the key global Trazodone Hydrochloride (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Trazodone Hydrochloride (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Trazodone Hydrochloride (API) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
To get Free Sample or to Buy this report at discounted price visit: https://www.nxtgenreports.com/market-research-reports/2018-2023-global-trazodone-hydrochloride-api
If you have any special requirements, kindly Contact Us and we will offer you the report as you want.
About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.
Contact Information:
Madhuri Vetal
NxtGen Reports
Email: sales@nxtgenreports.com
Phone: +918551022388
More Report at: https://www.nxtgenreports.com/market-research-reports
Contact Information:
NxtGen Reports
Madhuri Vetal
Tel: +918551022388
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
NxtGen Reports
Madhuri Vetal
Tel: +918551022388
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results